Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
Bouzas-Mosquera
Alberto
A
Vázquez-Rodríguez
José M
JM
D000111:Acetylcysteine / Q000627:therapeutic use*; D003287:Contrast Media / Q000009:adverse effects*; D003327:Coronary Disease / Q000175:diagnosis*; D003935:Diagnostic Techniques, Cardiovascular / Q000009:adverse effects*; D016166:Free Radical Scavengers / Q000627:therapeutic use; D006801:Humans; D011379:Prognosis; D051437:Renal Insufficiency / Q000139:chemically induced* / Q000517:prevention & control*; D012307:Risk Factors; D017693:Sodium Bicarbonate / Q000627:therapeutic use*
D003287:Contrast Media; D016166:Free Radical Scavengers; D017693:Sodium Bicarbonate; D000111:Acetylcysteine